Location: NEW YORK, NY
CIK: 0001633313 · Show all filings
Period: Q3 2022 (← Previous) (Next →)
Filing Date: Nov 14, 2022
Total Value ($000): $5,412,850 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| APLS | APELLIS PHARMACEUTICALS INC | 10,125,000 | $691,538 | 12.8% | $48.06 | +23.1% | Common | 03753U106 |
| UTHR | UNITED THERAPEUTICS CORP | 2,926,500 | $612,751 | 11.3% | $133.73 | +67.2% | Common | 91307C102 |
| ARGX | ARGENX SE | 1,265,555 | $446,804 | 8.3% | $136.82 | — | Sponsored ADR | 04016X101 |
| — | MIRATI THERAPEUTICS INC | 5,550,555 | $387,651 | 7.2% | $53.82 | — | Common | 60468T105 |
| SRPT | SAREPTA THERAPEUTICS INC | 3,175,000 | $350,965 | 6.5% | $97.25 | +3.6% | Common | 803607100 |
| — | HORIZON THERAPEUTICS PLC | 5,125,000 | $317,186 | 5.9% | $48.87 | — | Common | G46188101 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 3,555,555 | $301,404 | 5.6% | $83.64 | +6.5% | Common | 09061G101 |
| ASND | ASCENDIS PHARMA | 2,850,000 | $294,291 | 5.4% | $124.63 | — | Sponsored ADR | 04351P101 |
| FOLD | AMICUS THERAPEUTICS INC | 26,800,000 | $279,792 | 5.2% | $10.43 | +6.8% | Common | 03152W109 |
| — | SEAGEN INC | 1,865,000 | $255,188 | 4.7% | $146.44 | — | Common | 81181C104 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 1,105,000 | $221,177 | 4.1% | $153.75 | +24.1% | Common | 02043Q107 |
| XENE | XENON PHARMACEUTICALS INC | 4,900,000 | $176,890 | 3.3% | $16.29 | +120.7% | Common | 98420N105 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 9,050,000 | $114,030 | 2.1% | $12.22 | +5.3% | Common | 09058V103 |
| — | IVERIC BIO INC | 5,900,000 | $105,846 | 2.0% | $6.39 | — | Common | 46583P102 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 1,535,000 | $99,760 | 1.8% | $120.44 | -42.3% | Common | 558868105 |
| KRYS | KRYSTAL BIOTECH INC | 1,275,000 | $88,868 | 1.6% | $62.38 | +15.8% | Common | 501147102 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 9,020,000 | $86,412 | 1.6% | $16.40 | -29.7% | Common | 462260100 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 2,222,222 | $53,400 | 1.0% | $20.62 | +8.8% | Common | 87164F105 |
| — | MERSANA THERAPEUTICS INC | 7,550,000 | $51,038 | 0.9% | $21.34 | — | Common | 59045L106 |
| KURA | KURA ONCOLOGY INC | 3,525,000 | $48,152 | 0.9% | $23.38 | -34.0% | Common | 50127T109 |
| KYMR | KYMERA THERAPEUTICS INC | 2,169,230 | $47,224 | 0.9% | $35.72 | -26.2% | Common | 501575104 |
| WHWK | AADI BIOSCIENCES INC | 2,849,402 | $40,262 | 0.7% | $24.27 | -45.9% | Common | 00032Q104 |
| DSGN | DESIGN THERAPEUTICS INC | 2,222,222 | $37,156 | 0.7% | $25.91 | -23.2% | Common | 25056L103 |
| PMVP | PMV PHARMACEUTICALS INC | 3,060,000 | $36,414 | 0.7% | $25.09 | -42.4% | Common | 69353Y103 |
| — | CYMABAY THERAPEUTICS INC | 10,300,000 | $36,050 | 0.7% | $6.26 | — | Common | 23257D103 |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 750,000 | $31,058 | 0.6% | $64.00 | -19.7% | Common | 90400D108 |
| MNKD | MANNKIND CORP | 9,100,000 | $28,119 | 0.5% | $3.56 | +6.0% | Common | 56400P706 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 3,363,333 | $27,478 | 0.5% | $20.20 | -54.5% | Common | 61225M102 |
| RNAM | AVIDITY BIOSCIENCES INC | 1,450,000 | $23,679 | 0.4% | $24.02 | -20.4% | Common | 05370A108 |
| — | DICE THERAPEUTICS INC | 1,075,000 | $21,801 | 0.4% | $26.26 | — | Common | 23345J104 |
| — | MARINUS PHARMACEUTICALS INC | 3,150,000 | $20,948 | 0.4% | $12.20 | — | Common | 56854Q200 |
| NUVL | NUVALENT INC | 1,049,471 | $20,402 | 0.4% | $29.01 | -42.3% | Common | 670703107 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 650,000 | $18,298 | 0.3% | $24.95 | 0.0% | Common | 03237H101 |
| FENC | FENNEC PHARMACEUTICALS INC | 1,200,000 | $9,720 | 0.2% | $9.85 | -30.3% | Common | 31447P100 |
| RLAY | RELAY THERAPEUTICS INC | 400,000 | $8,948 | 0.2% | $21.43 | +2.4% | Common | 75943R102 |
| — | AMARIN CORP PLC | 6,000,000 | $6,540 | 0.1% | $8.22 | — | Sponsored ADR | 023111206 |
| TNGX | TANGO THERAPEUTICS INC | 1,550,000 | $5,611 | 0.1% | $11.99 | -64.4% | Common | 87583X109 |
| IOBT | IO BIOTECH INC | 2,055,883 | $5,571 | 0.1% | $9.66 | -61.6% | Common | 449778109 |
| BCAB | BIOATLA INC | 575,000 | $4,428 | 0.1% | $6.55 | 0.0% | Common | 09077B104 |